FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2570273488> ?p ?o ?g. }

• W2570273488 abstract "To compare the efficacy of sorafenib and sunitinib with regard to overall survival (OS) and progression free survival (PFS) in Chinese patients with metastatic renal cell carcinoma (mRCC). A multicenter, retrospective study was performed to elucidate the relationship between clinical variables and prognosis comparing sorafenib and sunitinib as first-line treatment agents in Chinese patients with mRCC. Between September 2006 and December 2014, 845 patients received either sorafenib (400 mg bid; n = 483) or sunitinib (50 mg q.d; n = 362). The primary end point was OS and PFS. The percentage of patients with low and moderate risk according to Memorial Sloan-Kettering Cancer Centre (MSKCC) score was significantly higher in sunitinib group, and that with high risk was significantly higher in sorafenib group (15.1 vs. 5.2%; p < 0.001). Median OS was similar in sorafenib and sunitinib group (24 vs. 24 months; p = 0.298). Sorafenib group exhibited higher mPFS compared to sunitinib group (11.1 vs. 10.0 months; p = 0.028). Treatment (sorafenib vs sunitinib), pathology, Eastern Cooperative Oncology Group (ECOG) performance status, MSKCC scores, Heng’s criteria of risk, and number of metastases were identified as significant predictors for OS and along with liver metastasis for PFS. Clinical outcomes in terms of mOS was significantly better with sorafenib in patients ≥65 years of age (p = .041), ECOG 0 (p = 0.0001), and median MSKCC risk score (p = 0.008). Sorafenib and sunitinib are both effective in treating mRCC. However, sorafenib might be more effective in elderly patients (≥65 years) and in patients with an ECOG status of 0, classified under MSKCC moderate risk." @default.
• W2570273488 created "2017-01-13" @default.
• W2570273488 creator A5007562507 @default.
• W2570273488 creator A5014398628 @default.
• W2570273488 creator A5022306208 @default.
• W2570273488 creator A5023004397 @default.
• W2570273488 creator A5032076802 @default.
• W2570273488 creator A5035535543 @default.
• W2570273488 creator A5047883899 @default.
• W2570273488 creator A5057428124 @default.
• W2570273488 date "2017-01-05" @default.
• W2570273488 modified "2023-10-16" @default.
• W2570273488 title "Sorafenib versus sunitinib as first-line treatment agents in Chinese patients with metastatic renal cell carcinoma: the largest multicenter retrospective analysis of survival and prognostic factors" @default.
• W2570273488 cites W1153576208 @default.
• W2570273488 cites W1564728191 @default.
• W2570273488 cites W1612927642 @default.
• W2570273488 cites W1652253116 @default.
• W2570273488 cites W1808168099 @default.
• W2570273488 cites W1966541767 @default.
• W2570273488 cites W1970779535 @default.
• W2570273488 cites W1971159432 @default.
• W2570273488 cites W1983200638 @default.
• W2570273488 cites W1995717891 @default.
• W2570273488 cites W1998151048 @default.
• W2570273488 cites W1999966467 @default.
• W2570273488 cites W2006181968 @default.
• W2570273488 cites W2015489672 @default.
• W2570273488 cites W2034151655 @default.
• W2570273488 cites W2047871200 @default.
• W2570273488 cites W2055229817 @default.
• W2570273488 cites W2061878103 @default.
• W2570273488 cites W2096057999 @default.
• W2570273488 cites W2100669312 @default.
• W2570273488 cites W2103689170 @default.
• W2570273488 cites W2110495372 @default.
• W2570273488 cites W2115731038 @default.
• W2570273488 cites W2116949558 @default.
• W2570273488 cites W2119183989 @default.
• W2570273488 cites W2121291141 @default.
• W2570273488 cites W2136110110 @default.
• W2570273488 cites W2138129102 @default.
• W2570273488 cites W2147186814 @default.
• W2570273488 cites W2147663823 @default.
• W2570273488 cites W2149456801 @default.
• W2570273488 cites W2157076786 @default.
• W2570273488 cites W2160724351 @default.
• W2570273488 cites W2162225483 @default.
• W2570273488 cites W2162427240 @default.
• W2570273488 cites W2167331614 @default.
• W2570273488 cites W2170552969 @default.
• W2570273488 cites W2245336291 @default.
• W2570273488 cites W2289315414 @default.
• W2570273488 cites W2334694951 @default.
• W2570273488 doi "https://doi.org/10.1186/s12885-016-3016-4" @default.
• W2570273488 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5217658" @default.
• W2570273488 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28056874" @default.
• W2570273488 hasPublicationYear "2017" @default.
• W2570273488 type Work @default.
• W2570273488 sameAs 2570273488 @default.
• W2570273488 citedByCount "17" @default.
• W2570273488 countsByYear W25702734882017 @default.
• W2570273488 countsByYear W25702734882019 @default.
• W2570273488 countsByYear W25702734882020 @default.
• W2570273488 countsByYear W25702734882021 @default.
• W2570273488 countsByYear W25702734882022 @default.
• W2570273488 countsByYear W25702734882023 @default.
• W2570273488 crossrefType "journal-article" @default.
• W2570273488 hasAuthorship W2570273488A5007562507 @default.
• W2570273488 hasAuthorship W2570273488A5014398628 @default.
• W2570273488 hasAuthorship W2570273488A5022306208 @default.
• W2570273488 hasAuthorship W2570273488A5023004397 @default.
• W2570273488 hasAuthorship W2570273488A5032076802 @default.
• W2570273488 hasAuthorship W2570273488A5035535543 @default.
• W2570273488 hasAuthorship W2570273488A5047883899 @default.
• W2570273488 hasAuthorship W2570273488A5057428124 @default.
• W2570273488 hasBestOaLocation W25702734881 @default.
• W2570273488 hasConcept C126322002 @default.
• W2570273488 hasConcept C143998085 @default.
• W2570273488 hasConcept C167135981 @default.
• W2570273488 hasConcept C203092338 @default.
• W2570273488 hasConcept C2777472916 @default.
• W2570273488 hasConcept C2778019345 @default.
• W2570273488 hasConcept C2778695046 @default.
• W2570273488 hasConcept C2779490328 @default.
• W2570273488 hasConcept C2779984678 @default.
• W2570273488 hasConcept C31760486 @default.
• W2570273488 hasConcept C535046627 @default.
• W2570273488 hasConcept C71924100 @default.
• W2570273488 hasConceptScore W2570273488C126322002 @default.
• W2570273488 hasConceptScore W2570273488C143998085 @default.
• W2570273488 hasConceptScore W2570273488C167135981 @default.
• W2570273488 hasConceptScore W2570273488C203092338 @default.
• W2570273488 hasConceptScore W2570273488C2777472916 @default.
• W2570273488 hasConceptScore W2570273488C2778019345 @default.
• W2570273488 hasConceptScore W2570273488C2778695046 @default.
• W2570273488 hasConceptScore W2570273488C2779490328 @default.
• W2570273488 hasConceptScore W2570273488C2779984678 @default.
• W2570273488 hasConceptScore W2570273488C31760486 @default.
• W2570273488 hasConceptScore W2570273488C535046627 @default.
• W2570273488 hasConceptScore W2570273488C71924100 @default.

• next